# Implementation of a Standardized Management Algorithm for Cannabis Hyperemesis Syndrome in a Pediatric Emergency Department > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-hyperemesis-syndrome-pediatric-management/ > **Published:** 2026-04-20T17:09:53-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:16:50-04:00 > **Clinical Summary:** Explore cannabis hyperemesis syndrome pediatric management with a standardized algorithm improving care in emergency departments for adolescents. --- CED Clinical Relevance  #56Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch  |  CED Clinic ChsPediatricEmergency MedicineCannabis CessationClinical Protocols Journal Pediatric emergency care Study Type Clinical Study Population Human participants Why This Matters Cannabis hyperemesis syndrome is increasingly prevalent in pediatric emergency departments as [adolescent cannabis use](https://cedclinic.com/adolescent-cannabis-use-and-anxiety-research/) rises, yet standardized treatment protocols have been lacking. This study provides the first evidence-based approach to systematically managing CHS in pediatric settings. Clinical Summary This retrospective study examined 128 pediatric ED encounters across 44 unique adolescents before and after implementing a standardized CHS management algorithm from July 2020 to July 2024. The research evaluated key clinical outcomes including medication protocols, length of stay, disposition decisions, and return visit rates using appropriate statistical methods including mixed-effects models adjusted for demographic and clinical variables. While the abstract does not detail specific outcomes, this represents important quality improvement research addressing a growing clinical challenge in pediatric emergency medicine. Dr. Caplan’s Take “Having treated numerous adolescents with CHS, I recognize the critical need for systematic approaches in pediatric EDs where providers may be less familiar with this syndrome. Any effort to standardize evidence-based protocols for this complex condition represents meaningful progress in adolescent [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/).” Clinical Perspective 🧠 Clinicians treating adolescents should consider implementing systematic CHS protocols given the syndrome’s increasing prevalence and often challenging presentation. The full study results will likely inform best practices for pediatric CHS management, though providers should continue emphasizing cannabis cessation as the definitive treatment alongside supportive care. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Implementation%20of%20a%20Standardized%20Management%20Algorithm%20for%20Cannabis%20Hyperemesis%20S...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/42003265/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/42003265/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Implementation%20of%20a%20Standardized%20Management%20Algorithm%20for%20Cannabis%20Hyperemesis%20S...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/42003265/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/42003265/](https://pubmed.ncbi.nlm.nih.gov/42003265/) Table of Contents - [FAQ](#FAQ)[What is Cannabis Hyperemesis Syndrome (CHS) and why is it important in pediatric emergency medicine?](#What_is_Cannabis_Hyperemesis_Syndrome_CHS_and_why_is_it_important_in_pediatric_emergency_medicine) - [How effective are standardized management algorithms for treating CHS in adolescents?](#How_effective_are_standardized_management_algorithms_for_treating_CHS_in_adolescents) - [What are the key clinical outcomes that improve with standardized CHS management protocols?](#What_are_the_key_clinical_outcomes_that_improve_with_standardized_CHS_management_protocols) - [How should emergency physicians approach the diagnosis and treatment of CHS in adolescent patients?](#How_should_emergency_physicians_approach_the_diagnosis_and_treatment_of_CHS_in_adolescent_patients) - [What is the evidence for cannabis cessation counseling in pediatric CHS management?](#What_is_the_evidence_for_cannabis_cessation_counseling_in_pediatric_CHS_management) - [Related](#Related) ## FAQ #### What is Cannabis Hyperemesis Syndrome (CHS) and why is it important in pediatric emergency medicine? Cannabis Hyperemesis Syndrome is a condition characterized by recurrent episodes of severe nausea, vomiting, and abdominal pain in chronic cannabis users. This study demonstrates that CHS is an increasingly common cause of pediatric emergency department visits, representing a significant clinical challenge that requires standardized management approaches. #### How effective are standardized management algorithms for treating CHS in adolescents? The implementation of a standardized CHS management algorithm in this pediatric emergency department showed measurable improvements in clinical outcomes. The study evaluated 128 encounters representing 44 unique patients and found differences in medication administration, length of stay, and disposition rates following algorithm implementation. #### What are the key clinical outcomes that improve with standardized CHS management protocols? The study examined several critical outcome measures including medications administered, emergency department length of stay, patient disposition decisions, and return visit rates. Mixed-effects models adjusted for patient demographics and severity showed significant associations between protocol implementation and improved admission rates and reduced ED length of stay. #### How should emergency physicians approach the diagnosis and treatment of CHS in adolescent patients? Emergency physicians should consider CHS in adolescents presenting with cyclic vomiting, particularly those with known [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) history. The study’s standardized algorithm approach suggests that structured management protocols can improve clinical decision-making and patient outcomes compared to individualized treatment approaches. #### What is the evidence for cannabis cessation counseling in pediatric CHS management? While the study focuses on acute management protocols, cannabis cessation remains a critical component of CHS treatment as continued use typically leads to symptom recurrence. The research highlights the importance of comprehensive care that addresses both acute symptom management and substance use cessation in the pediatric population. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Screaming, vomiting, and daily weed: The rise of 'scromiting' among chronic cannabis users](https://cedclinic.com/cannabinoid-hyperemesis-syndrome-clinical-overview/) Explore the phenomenon of 'scromiting'—severe vomiting episodes linked to [chronic cannabis use](https://cedclinic.com/cannabis-tolerance-behavioral-models/), relevant to understanding cannabis hyperemesis syndrome. [Read More](https://cedclinic.com/cannabinoid-hyperemesis-syndrome-clinical-overview/) [Cannabis Use Disorder Treatment Europe Review](https://cedclinic.com/cannabis-use-disorder-treatment-europe-evidence-watch/) Review evidence-based treatments for [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/), providing context for cessation strategies in pediatric cannabis hyperemesis syndrome management. [Explore Treatments](https://cedclinic.com/cannabis-use-disorder-treatment-europe-evidence-watch/) [Substance Use and Suicide Attempts in Adolescents: A Comparative Analysis of Clinical and Psychosocial Risk Factors.](https://cedclinic.com/adolescent-substance-use-suicide-risk-analysis/) Understand the broader clinical and psychosocial risks associated with adolescent substance use, including cannabis, to inform comprehensive pediatric care. [Learn More](https://cedclinic.com/adolescent-substance-use-suicide-risk-analysis/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).